CervoMed Inc.
CRVO
$9.49
$0.060.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.33% | -11.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.33% | -11.31% | |||
| Cost of Revenue | 5.60% | -31.73% | |||
| Gross Profit | -14.75% | 40.70% | |||
| SG&A Expenses | 37.05% | 2.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.98% | -23.21% | |||
| Operating Income | -24.77% | 26.76% | |||
| Income Before Tax | -27.88% | 27.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.88% | 27.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.88% | 27.02% | |||
| EBIT | -24.77% | 26.76% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -24.32% | 26.97% | |||
| Normalized Basic EPS | -24.32% | 26.97% | |||
| EPS Diluted | -24.32% | 26.97% | |||
| Normalized Diluted EPS | -24.32% | 26.97% | |||
| Average Basic Shares Outstanding | 2.85% | -0.05% | |||
| Average Diluted Shares Outstanding | 2.85% | -0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||